1. South Korea Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
APTOCROM Inc.

APTOCROM Inc.

KKRX:109960
1,805.00
KRW
-32.00
(-1.74%)
-708.31EPS
36.20BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
95,060.88
20,175.52
39,577.05
27,651.12
11,420.73
14,279.95
12,321.83
5,771.82
4,714.16
26,852.95
5,950.25
2,545.19
917.32
822.59
Basic EPS, GAAP
-16,842.54
-300
-9,100.01
-64,049.94
-3,352.12
7,100
-3,800
6,200
1,484.26
6,800
1,600
-4,360
-520
-692.01
Free Cash Flow per Basic Share
861.09
-397.21
-7,803.52
-31,730.8
620.41
2,737.9
500.62
1,877.27
-7,681.65
48,357.27
607.45
717.79
226.51
304.94
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
20,198.85
19,448.89
44,980.84
20,077.23
114,335.51
121,802.1
117,903.18
129,853.15
124,691.99
115,902.04
50,351.68
30,067.42
27,776.93
27,503.78
Tangible Book Value per Share
18,960.85
16,614.11
43,212.29
13,097.44
113,350.96
121,350.24
117,899.34
129,851.47
124,682.49
115,896.75
50,350.69
30,067.19
27,776.78
27,503.39
Basic Weighted Avg Shares
- -
1
- -
- -
1
1
2
2
2
- -
3
6
11
11
Sales/Revenue/Turnover
20,704
13,468
11,117
9,821
11,242
17,580
21,901
10,319
8,416
9,598
16,007
16,400
9,807
8,887
Operating Margin (%)
-11.12
3.35
-20.47
-98.63
-23.18
-1.49
-2.9
-3.64
-30.65
-9.69
3.51
25.89
5.62
39.19
Depreciation Expense
567
330
374
974
726
513
703
397
413
289
550
430
365
355
Net Income, GAAP
-3,668
-200
-2,556
-22,750
-3,300
8,741
-6,754
11,084
2,650
2,431
4,304
-28,094
-5,559
-7,477
Effective Tax Rate (%)
- -
867.81
- -
- -
- -
1.99
- -
- -
- -
12.46
25.21
- -
- -
- -
Profit Margin (%)
-17.72
-1.49
-22.99
-231.64
-29.35
49.72
-30.84
107.42
31.49
25.32
26.89
-171.3
-56.69
-84.13
Working Capital
1,337
1,560
12,798
5,012
54,967
49,943
77,239
97,331
109,123
95,983
-7,079
21,547
23,056
23,436
LT Debt
466
222
136
81
27
- -
172
143
38
89
16
20
30
23
Total Equity
4,402
4,239
15,077
9,198
114,687
217,202
210,147
231,457
222,240
207,474
287,265
301,856
306,569
303,450
Return on Invested Capital (%)
- -
-43.57
- -
- -
- -
-0.14
- -
- -
-1.14
-0.37
0.05
- -
- -
- -
Return on Capital (%)
- -
-22.53
- -
- -
- -
5.84
- -
- -
1.17
1.13
2.33
- -
- -
- -
Return on Common Equity (%)
-59.22
-4.64
-26.47
-191.82
-5.35
5.26
-3.16
5.01
1.17
1.13
1.74
-9.54
-1.83
-2.47

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
6,168
6,214
6,222
LT Borrowings
- -
- -
- -
LT Finance Leases
38
30
23
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
72,849
55,189
36,204

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
55,516
34,768
35,501
Cash, Cash Equivalents & STI
25,512
23,436
21,829
Accounts Receivable, Net
1,741
1,657
1,667
Inventories
1,477
1,388
1,383
Total Current Liabilities
13,234
11,712
12,065
Payables & Accruals
- -
- -
- -
ST Debt
6,168
6,214
6,222
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
123.86%
6.9%
1.56%
Free Cash Flow
27.44%
-137.96%
-47.64%
Net Income, GAAP
-94.2%
-168.04%
-80.21%
Sales/Revenue/Turnover
5.55%
4.93%
-40.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,401
4,924
3,300
4,775
16,400
2025
3,342
1,508
2,529
2,428
9,807
2026
2,423
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
8,309.56
-4,820
2,900
-6,437.53
-4,360
2025
-119.61
14.8
-105.45
-303.01
-520
2026
-282.47
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jung-Chool Kim
Full Time Employees
16
Sector
Distribution services
Industry
Medical distributors
Address
Seongnam South Korea
IPO Date
Nov 17, 2009
Website
ap-healthcare.co.kr
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
APTOCROM Inc. operates as a diversified enterprise engaged in pharmaceutical distribution, specialized industrial insulation engineering, and commercial property leasing in South Korea. The company operates across three primary business divisions: Pharmaceuticals, Industrial Insulation, and Leasing. Its Pharmaceuticals division distributes and commercializes prescription and over-the-counter therapeutic products, including gastrointestinal and digestive remedies such as Ejilong oral solution and Gabespan soft capsules; dermatological and topical preparations such as Ravenda cream and Valclox ointment; systemic antibiotic preparations; and metabolic alteratives and nutritional tonics. Its Industrial Insulation division engages in the engineering, fabrication, and installation of specialized thermal and cryogenic insulation solutions for power plants and heavy industrial facilities, supplying removable insulation blankets, cellular foam glass materials, and specialized containment insulation for nuclear power generation systems. The Leasing division manages the rental of commercial office spaces, research laboratory facilities, and pharmaceutical manufacturing equipment. In September 2025, the company completed a major corporate rebranding, officially changing its name from AP Healthcare Inc. (previously Aprogen Healthcare & Games Inc.) to APTOCROM Inc. Following this restructuring, the company expanded its business scope to encompass digital asset and blockchain technology solutions, transitioning away from legacy mobile game publishing operations to focus on core healthcare distribution, industrial engineering, and emerging technologies. Founded on February 12, 1998, APTOCROM Inc. is headquartered in Seongnam-si, Gyeonggi-do, South Korea.